Resources
HealthEconomics.com November 15, 2023 Listen to the full podcast >> The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Joseph Zabinski, Managing Director of AI and Personalized Medicine[…]
Healthcare Innovation September 19, 2023 Read the full article >> Congratulations to 40 Under 40 Winner: Joseph Zabinski, PhD, MEM, Managing Director of AI & Personalized Medicine, OM1 Get To Know Joseph: Age (as of December 31, 2023): 35 Hometown: Cortlandt Manor, NY Alma Mater: Boston College (BS), Dartmouth (MEM), UNC (PhD) Number of Years of Experience in Healthcare: 8[…]
November 1, 2023 BioPharma Reporter Read the full article >> Kathryn Starzyk is an epidemiologist and currently vice president of real-world evidence (RWE) at healthcare technology company, OM1.
November 1, 2023 The Evidence Base Read the full article >> In a recent presentation at the DIA Real-Word Evidence (RWE) Conference (October 16–17, 2023, Baltimore, MD, USA), Sonja Wustrack, Managing Director of Integrated Evidence Generation at OM1 (MA, USA), discussed strategies for optimizing evidence generation in clinical research. She described the OM1 approach to[…]
HIT Consultant October 3, 2023 Read the full article >> What You Should Know: – OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. – Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient[…]
